A Novel Live-Attenuated Vaccine Candidate for Mayaro Fever

被引：52
作者：
Weise, William J. [1 ]
Hermance, Meghan E.
Forrester, Naomi
Adams, A. Paige
Langsjoen, Rose
Gorchakov, Rodion
Wang, Eryu
Alcorn, Maria D. H.
Tsetsarkin, Konstantin
Weaver, Scott C.
机构：
[1] Univ Texas Med Branch, Inst Human Infect & Immun, Ctr Trop Dis, Galveston, TX 77555 USA
来源：
PLOS NEGLECTED TROPICAL DISEASES | 2014年 / 8卷 / 08期
基金：
美国国家卫生研究院;
关键词：
EQUINE ENCEPHALITIS-VIRUS; CHIKUNGUNYA VIRUS; CYNOMOLGUS MACAQUES; ENCEPHALOMYELITIS VIRUS; NONHUMAN-PRIMATES; AMAZON BASIN; INFECTION; DISEASE; STRAIN; ALPHAVIRUSES;
D O I：
10.1371/journal.pntd.0002969
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Mayaro virus (MAYV) is an emerging, mosquito-borne alphavirus that causes a dengue-like illness in many regions of South America, and which has the potential to urbanize. Because no specific treatment or vaccine is available for MAYV infection, we capitalized on an IRES-based approach to develop a live-attenuated MAYV vaccine candidate. Testing in infant, immunocompetent as well as interferon receptor-deficient mice demonstrated a high degree of attenuation, strong induction of neutralizing antibodies, and efficacy against lethal challenge. This vaccine strain was also unable to infect mosquito cells, a major safety feature for a live vaccine derived from a mosquito-borne virus. Further preclinical development of this vaccine candidate is warranted to protect against this important emerging disease.
引用
收藏
页数：9
相关论文
共 50 条
  • [21] A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate
    Sanchez-Felipe, Lorena
    Vercruysse, Thomas
    Sharma, Sapna
    Ma, Ji
    Lemmens, Viktor
    Van Looveren, Dominique
    Arkalagud Javarappa, Mahadesh Prasad
    Boudewijns, Robbert
    Malengier-Devlies, Bert
    Liesenborghs, Laurens
    Kaptein, Suzanne J. F.
    De Keyzer, Carolien
    Bervoets, Lindsey
    Debaveye, Sarah
    Rasulova, Madina
    Seldeslachts, Laura
    Li, Li-Hsin
    Jansen, Sander
    Yakass, Michael Bright
    Verstrepen, Babs E.
    Boszormenyi, Kinga P.
    Kiemenyi-Kayere, Gwendoline
    van Driel, Nikki
    Quaye, Osbourne
    Zhang, Xin
    ter Horst, Sebastiaan
    Mishra, Niraj
    Deboutte, Ward
    Matthijnssens, Jelle
    Coelmont, Lotte
    Vandermeulen, Corinne
    Heylen, Elisabeth
    Vergote, Valentijn
    Schols, Dominique
    Wang, Zhongde
    Bogers, Willy
    Kuiken, Thijs
    Verschoor, Ernst
    Cawthorne, Christopher
    Van Laere, Koen
    Opdenakker, Ghislain
    Vande Velde, Greetje
    Weynand, Birgit
    Teuwen, Dirk E.
    Matthys, Patrick
    Neyts, Johan
    Jan Thibaut, Hendrik
    Dallmeier, Kai
    NATURE, 2021, 590 (7845) : 320 - 325
  • [22] Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design
    VanBuskirk, Kelley M.
    O'Neill, Matthew T.
    De la Vega, Patricia
    Maier, Alexander G.
    Krzych, Urszula
    Williams, Jack
    Dowler, Megan G.
    Sacci, John B., Jr.
    Kangwanrangsan, Niwat
    Tsuboi, Takafumi
    Kneteman, Norman M.
    Heppner, Donald G., Jr.
    Murdock, Brant A.
    Mikolajczak, Sebastian A.
    Aly, Ahmed S. I.
    Cowman, Alan F.
    Kappe, Stefan H. I.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (31) : 13004 - 13009
  • [23] Reverse genetic platform for inactivated and live-attenuated influenza vaccine
    Jung, Eun-Ju
    Lee, Kwang-Hee
    Seong, Baik Lin
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2010, 42 (02) : 116 - 121
  • [24] A Novel Live Attenuated Vaccine Candidate Protects Against Heterologous Senecavirus A Challenge
    Sharma, Bishwas
    Fernandes, Maureen H., V
    de Lima, Marcelo
    Joshi, Lok R.
    Lawson, Steve
    Diel, Diego G.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [25] Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms
    Okutani, Mie Suzuki
    Okamura, Shinya
    Gis, Tang
    Sasaki, Hitomi
    Lee, Suni
    Kashiwabara, Akiho
    Goto, Simon
    Matsumoto, Mai
    Yamawaki, Mayuko
    Miyazaki, Toshiaki
    Nakagawa, Tatsuya
    Ikawa, Masahito
    Kamitani, Wataru
    Takekawa, Shiro
    Yamanishi, Koichi
    Ebina, Hirotaka
    ELIFE, 2025, 13
  • [26] Identification of a Live Attenuated Vaccine Candidate for Tularemia Prophylaxis
    Mahawar, Manish
    Rabadi, Seham M.
    Banik, Sukalyani
    Catlett, Sally V.
    Metzger, Dennis W.
    Malik, Meenakshi
    Bakshi, Chandra Shekhar
    PLOS ONE, 2013, 8 (04):
  • [27] Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine
    Chang, Yie-Hwa
    Duong, Duc M.
    Goll, Johannes B.
    Wood, David C.
    Jensen, Travis L.
    Yin, Luming
    Gelber, Casey E.
    Seyfried, Nicholas T.
    Anderson, Evan
    Natrajan, Muktha S.
    Rouphael, Nadine
    Johnson, Robert A.
    Sanz, Patrick
    Mulligan, Mark J.
    Hoft, Daniel F.
    VACCINES, 2020, 8 (03) : 1 - 22
  • [28] Development of a live-attenuated chimeric vaccine against the emerging Usutu virus
    Wang, Zheng-Jian
    Zhang, Rong-Rong
    Wu, Mei
    Zhao, Hui
    Li, Xiao-Feng
    Ye, Qing
    Qin, Cheng-Feng
    VACCINE, 2024, 42 (06) : 1363 - 1371
  • [29] A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates
    Kari, Laszlo
    Whitmire, William M.
    Olivares-Zavaleta, Norma
    Goheen, Morgan M.
    Taylor, Lacey D.
    Carlson, John H.
    Sturdevant, Gail L.
    Lu, Chunxue
    Bakios, Lauren E.
    Randall, Linnell B.
    Parnell, Michael J.
    Zhong, Guangming
    Caldwell, Harlan D.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (11) : 2217 - 2223
  • [30] An RSV Live-Attenuated Vaccine Candidate Lacking G Protein Mucin Domains Is Attenuated, Immunogenic, and Effective in Preventing RSV in BALB/c Mice
    Roe, Molly K.
    Perez, Maria A.
    Hsiao, Hui-Mien
    Lapp, Stacey A.
    Sun, He-Ying
    Jadhao, Samadhan
    Young, Audrey R.
    Batista, Yara S.
    Reed, Ryan C.
    Taz, Azmain
    Piantadosi, Anne
    Chen, Xuemin
    Liang, Bo
    Koval, Michael
    Snider, Timothy A.
    Moore, Martin L.
    Anderson, Evan J.
    Anderson, Larry J.
    Stobart, Christopher C.
    Rostad, Christina A.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 227 (01) : 50 - 60
12345